financetom
Business
financetom
/
Business
/
#BoycottMcDonalds: McDonald’s India lands in hot water over Halal meat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
#BoycottMcDonalds: McDonald’s India lands in hot water over Halal meat
Aug 27, 2019 4:09 AM

McDonald’s India finds hard to tackle the heat of #BoycottMcDonalds movement led by the right-wing Hindus after it declared the use of Halal meat in all of its outlets.

Share Market Live

NSE

The whole controversy erupted after a Twitter user @hibailyas89 asked McDonald's India if its restaurants in India carry halal certification. In its reply, the fast-food chain said, "All our restaurants have HALAL certificates. You can ask the respective restaurant managers to show you the certificate for your satisfaction and confirmation."

After its reply, the global fast-food chain faced a sever backlash on Twitter. Many questioned why it is using Halal meat despite having more than 80 percent of Hindus and Sikhs customers. However, the McDonald’s menu in India has no beef or pork products, but a range of chicken, fish and vegetarian options.

Halal certification indicates that animals were slaughtered according to the Muslim tradition, which is often opposed by the majority of Hindus and Sikhs.

Noted lawyer Ishkaran Bhandari has raised the issue and said that he will definitely sue MacDonald’s for imposing food habits.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novartis to Acquire Excellergy For Up to $2 Billion
Novartis to Acquire Excellergy For Up to $2 Billion
Mar 27, 2026
03:34 AM EDT, 03/27/2026 (MT Newswires) -- Novartis AG ( NVS ) said Friday it agreed to buy private biotechnology firm Excellergy for as much as $2 billion in initial and milestone payments. The proposed transaction includes an experimental early-stage IgE medication called Exl-111 designed to treat various allergic conditions, the company said. The clinical therapy targets a specific biological...
Novo Nordisk's Once-Weekly Diabetes Drug Receives FDA Approval
Novo Nordisk's Once-Weekly Diabetes Drug Receives FDA Approval
Mar 27, 2026
03:27 AM EDT, 03/27/2026 (MT Newswires) -- Novo Nordisk ( NVO ) said late Thursday the US Food and Drug Administration has approved its experimental drug, Awiqli, as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. The company said the drug is the first once-weekly basal insulin option, offering an alternative to...
Astrazeneca Says Potential Pulmonary Disease Drug Meets Primary Endpoint in Phase 3 Studies
Astrazeneca Says Potential Pulmonary Disease Drug Meets Primary Endpoint in Phase 3 Studies
Mar 27, 2026
04:13 AM EDT, 03/27/2026 (MT Newswires) -- Astrazeneca ( AZN ) said Friday that its drug tozorakimab met its primary endpoint in two phase 3 trials in patients with chronic obstructive pulmonary disease. The company said the trials showed that tozorakimab reduced the annualized rate of moderate-to-severe chronic obstructive pulmonary disease exacerbations compared with placebo among both former smokers and...
Bristow Group Insider Sold Shares Worth $1,347,049, According to a Recent SEC Filing
Bristow Group Insider Sold Shares Worth $1,347,049, According to a Recent SEC Filing
Mar 27, 2026
04:15 AM EDT, 03/27/2026 (MT Newswires) -- Christopher Scott Bradshaw, Director, President and Chief Executive Officer, on March 24, 2026, sold 29,625 shares in Bristow Group ( VTOL ) for $1,347,049. Following the Form 4 filing with the SEC, Bradshaw has control over a total of 302,938 common shares of the company, with 302,938 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1525221/000152522126000057/xslF345X05/form4.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved